TIDES 2024
Event Details
IM in pharma has grown in 10 years. Hyphenated with LC-MS, IM aids in peptide ID. A case study shows how SLIM HRIM can be used to study peptide therapeutics.
Ion mobility (IM) interest and implementation has grown in pharmaceutical industry over the last 10 years. IM technology can be hyphenated with traditional LC-MS providing an orthogonal separation to aid in the identification of isomeric modified peptides. A review of commercially available IM with a case study to demonstrate how structures for lossless ion manipulation (SLIM) high resolution ion mobility (HRIM) can be leveraged to study peptide therapeutics.
May 14-17, 2024
Boston, MA
#1106